Patients in Castion are facing a transition in their primary healthcare services following the cessation of activity by Dr. Nazario Ponticiello. To ensure the continuity of medical assistance, affected residents are being reassigned to the care of Dr. Federica Pavan, a physician with extensive specialized training in pharmacology and clinical medicine.
This administrative shift is part of the broader effort to maintain stable healthcare access within the region. For many patients, the transition of a primary care physician can be a period of uncertainty, but the assignment of a practitioner with a robust academic and clinical background aims to mitigate disruptions in long-term treatment and preventative care.
As an Editor of Health with over a decade of experience in internal medicine and medical journalism, I have seen how critical these transitions are for public health. Ensuring that patients are matched with qualified providers is essential for managing chronic conditions and maintaining the integrity of the patient-provider relationship.
Who is Dr. Federica Pavan?
Dr. Federica Pavan brings a highly specialized set of credentials to her role as a primary care physician. She earned her degree in Medicine and Surgery from the University of Udine in 2001, where her experimental thesis focused on the interindividual pharmacokinetic variability of antiretroviral drugs in HIV-positive patients, conducted in collaboration with the Division of Infectious Diseases at the OC “Ca’ Foncello” in Treviso Belluno Medica.
Beyond general practice, Dr. Pavan is a specialist in Pharmacology, having completed her specialization with maximum honors at the University of Udine in 2005 Belluno Medica. Her expertise extends into complex therapeutic monitoring and drug interactions, providing a depth of knowledge that is particularly beneficial for patients requiring complex medication regimens.
Dr. Pavan’s career includes significant contributions to medical research and the pharmaceutical industry. From April 2008 to March 2010, she served as an HIV Medical Scientist for GlaxoSmithKline in Northeast Italy, and subsequently held a similar role at ViiV Healthcare S.r.l. From April 2010 to April 2012 Belluno Medica. She was the winner of the Trabucchi prize for young researchers for her function on renal tolerance during high-dose teicoplanin therapy in patients with osteomyelitis or joint prosthesis infections.
Practice Location and Access for Patients
Dr. Pavan operates her primary care activity in Mel. Her office is located at Via Roma 17, 32026 Mel, within the facilities of the Distretto Sanitario AULSS 1 Dolomiti. This location has served as a hub for primary assistance in the area, previously hosting other practitioners such as Dr. Mario Bortot, who ceased his activity on June 30, 2024, with Dr. Pavan taking over the practice on July 1, 2024 AULSS 1 Dolomiti.
To streamline patient care and reduce administrative delays, Dr. Pavan utilizes digital tools for scheduling and prescriptions. Patients are encouraged to employ the MioDottore portal for booking appointments and requesting prescriptions MioDottore. Although appointments can be booked during weekends via the portal, prescription requests are typically handled during standard business hours.
Key Information for Transitioning Patients
| Detail | Information |
|---|---|
| Outgoing Physician | Dr. Nazario Ponticiello |
| Incoming Physician | Dr. Federica Pavan |
| Clinic Address | Via Roma 17, Mel 32026 |
| Booking Method | MioDottore Portal |
| Specialization | Pharmacology |
What So for Healthcare Continuity
The assignment of patients from one physician to another is a standard procedure managed by local health authorities to prevent “medical voids.” In this instance, the transition from Dr. Ponticiello to Dr. Pavan ensures that residents of Castion maintain a legal and clinical link to the national health system.
The inclusion of a physician with a specialization in pharmacology is a notable asset for the community. Pharmacology specialists are trained to optimize drug therapy, minimize adverse reactions, and manage polypharmacy—which is especially critical for elderly patients or those with multiple co-morbidities. Dr. Pavan’s history with the Comitato Etico Indipendente (C.E.I) of the University of Udine, where she monitored adverse drug reactions in clinical trials between 2008 and 2010, further underscores her commitment to patient safety Belluno Medica.
Patients transitioning to a new provider should prepare for their first visit by gathering their current medication lists, recent lab results, and a summary of their chronic conditions. This allows the new physician to quickly integrate the patient’s medical history and maintain the trajectory of their care.
For further official updates regarding patient assignments or to verify the status of their medical record transfer, residents are advised to contact their local AULSS 1 Dolomiti office or check the official regional health portals.
We encourage readers to share this information with neighbors or family members in the Castion and Mel areas who may be affected by this change in medical providers. Please abandon your comments or questions below.
Related reading